feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Die angezeigten Daten werden derzeit aktualisiert.
Derzeit steht der Fernleihindex leider nicht zur Verfügung.
Export
  • 1
    Online Resource
    Online Resource
    Frontiers Media SA ; 2022
    In:  Frontiers in Oncology Vol. 12 ( 2022-12-14)
    In: Frontiers in Oncology, Frontiers Media SA, Vol. 12 ( 2022-12-14)
    Abstract: In this study, DOTA-IBA was radiolabeled with 68 Ga and we determined the optimum labelling conditions and assessed the biological properties of 68 Ga-DOTA-IBA. We investigated the biodistribution of 68 Ga-DOTA-IBA in normal animals and undertook PET/CT imaging in humans. Finally, we explored the feasibility 68 Ga-DOTA-IBA as a bone imaging agent and demonstrated its potential for the therapeutic release of 177 Lu/ 225 Ac-DOTA-IBA. Methods The controlled variables method was used to assess the impact of variables on the radiochemical purity of 68 Ga-DOTA-IBA. The biological properties of 68 Ga-DOTA-IBA were investigated. 68 Ga-DOTA-IBA micro-PET/CT imaging was performed on animals. Volunteers were recruited for 68 Ga-DOTA-IBA imaging and data were compared to 99m Tc-MDP imaging studies to calculate the target to non-target ratio (T/NT) of the lesions. Results The prepared 68 Ga-DOTA-IBA had a radiochemical purity of & gt;97% and demonstrated good biological properties with a good safety profile in normal mice. PET/CT imaging of the animals showed rapid blood clearance with high contrast between the bone and stroma. Human imaging showed that 68 Ga-DOTA-IBA could detect more lesions compared to 99m Tc-MDP and had a higher targeted to untargeted ratio. Conclusions 68 Ga-DOTA-IBA is an osteophilic radiopharmaceutical that can be synthesized using a simple labelling method. 68 Ga-DOTA-IBA has high radiochemical purity and is stable in vitro stability. It is rapidly cleared from the blood, has low toxicity and has strong targeting to the bone with long retention times. We also found that it is rapidly cleared in non-target tissues and has high contrast on whole-body bone imaging. 68 Ga-DOTA-IBA PET/CT has potential as a novel bone imaging bone modality in patients with metastatic disease.
    Type of Medium: Online Resource
    ISSN: 2234-943X
    Language: Unknown
    Publisher: Frontiers Media SA
    Publication Date: 2022
    detail.hit.zdb_id: 2649216-7
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    In: JAMA Network Open, American Medical Association (AMA), Vol. 6, No. 2 ( 2023-02-16), p. e2255609-
    Abstract: Adrenal vein sampling (AVS) is the recommended procedure for subtyping primary aldosteronism (PA) as unilateral PA (UPA) or bilateral PA (BPA), with different treatment needed for each: adrenalectomy for UPA and medication for BPA. However, AVS is invasive and technically difficult, and how to subtype PA noninvasively is currently a great challenge. Objective To evaluate the accuracy of gallium-68 pentixafor positron emission tomography–computed tomography (PET-CT) in subtyping PA using AVS as a reference standard. Design, Setting, and Participants This diagnostic study was conducted at a tertiary hospital in China among patients diagnosed with PA. Enrollment was started in November 2021, with follow-up ending in May 2022. Exposures : Patients were recruited to undergo gallium-68 pentixafor PET-CT and AVS. Main Outcomes and Measures Maximum standardized uptake value (SUVmax) of each adrenal gland during PET-CT was measured to calculate the lateralization index of SUVmax. Area under the receiver operating characteristic curve (AUROC), specificity, and sensitivity were used to analyze the accuracy of the lateralization index based on SUVmax for subtyping PA. Results Among 100 patients with PA who completed the study (47 female [47.0%] and 53 male [53.0%] ; median [IQR] age, 49 [38-56] years), 43 individuals had UPA and 57 individuals had BPA. Aldosterone-cortisol ratio (Spearman ρ = 0.26; P   & amp;lt; .001) in adrenal veins was positively correlated with SUVmax of adrenal glands at 10 minutes during PET-CT. Using lateralization index based on SUVmax at 10 minutes to identify UPA, the AUROC was 0.90 (95% CI, 0.83-0.97). A cutoff value for lateralization index based on SUVmax at 10 minutes set at 1.65 conferred a specificity of 1.00 (95% CI, 0.94-1.00) and sensitivity of 0.77 (95% CI, 0.61-0.88). The diagnostic concordance rate of PET-CT and AVS was 90 patients (90.0%) compared with 54 patients (54.0%) between traditional CT and AVS. Conclusions and Relevance This study found good diagnostic accuracy of gallium-68 pentixafor PET-CT in differentiating UPA from BPA. These findings suggest that gallium-68 pentixafor PET-CT may be used to avoid invasive AVS in some patients with PA.
    Type of Medium: Online Resource
    ISSN: 2574-3805
    Language: English
    Publisher: American Medical Association (AMA)
    Publication Date: 2023
    detail.hit.zdb_id: 2931249-8
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages